Chapter 18: Gastrointestinal Alterations

The mucosa serves as a critical protective barrier against bacterial invasion and gastric acid damage. The pancreas functions in dual capacity as both an exocrine organ producing digestive enzymes and an endocrine organ secreting insulin and glucagon, with ischemic injury triggering release of myocardial depressant factor that further compromises cardiac output. The liver performs over four hundred metabolic functions including bile production, bilirubin processing, and detoxification while receiving substantial blood flow from both hepatic arterial and portal venous sources. Comprehensive assessment requires systematic physical examination following inspection, auscultation, percussion, and palpation in proper sequence, with careful attention to bowel sound characteristics across all abdominal quadrants. Acute gastrointestinal bleeding presents through hematemesis and melena, commonly originating from peptic ulcer disease associated with Helicobacter pylori infection or nonsteroidal anti-inflammatory drug use, as well as stress ulcers, Mallory-Weiss tears, and esophageal varices. Management prioritizes hemodynamic stabilization through large-bore intravenous access and fluid resuscitation, followed by endoscopic intervention and pharmacologic acid suppression using proton pump inhibitors and histamine-2 receptor antagonists. Acute pancreatitis develops through premature enzyme activation causing pancreatic autodigestion, most frequently triggered by alcohol consumption or biliary obstruction, presenting with severe epigastric pain radiating posteriorly along with characteristic physical findings including Grey Turner's sign and Cullen's sign. Severity assessment utilizes Ranson Criteria and APACHE scoring systems, while management emphasizes aggressive fluid replacement, opioid analgesia, and early enteral nutrition to preserve gastrointestinal integrity. Hepatic failure resulting from hepatitis or cirrhotic change produces multiple complications including portal hypertension, esophageal varices, ascites requiring paracentesis and dietary sodium restriction, portal systemic encephalopathy managed through lactulose and antimicrobial therapy to reduce ammonia levels, and hepatorenal syndrome representing acute kidney injury with grave prognosis. The chapter addresses pharmacogenomic variations in cytochrome P450 enzyme metabolism affecting drug efficacy and safety, and lifespan considerations including heightened malnutrition risk in elderly populations and gastrointestinal manifestations during pregnancy.